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Abstract
In maternal diabetes, the fetal heart can be structurally and functionally affected. Maternal
diets enriched in certain unsaturated fatty acids can activate the nuclear receptors peroxisome
proliferator-activated receptors (PPARs) and regulate metabolic and anti-inflammatory
pathways during development. Our aim was to investigate whether PPARa expression, lipid
metabolism, lipoperoxidation, and nitric oxide (NO) production are altered in the fetal hearts of
diabetic rats, and to analyze the putative effects of in vivo PPAR activation on these parameters.
We found decreased PPARa expression in the hearts of male but not female fetuses of diabetic
rats when compared with controls. Fetal treatments with the PPARa ligand leukotriene B4
upregulated the expression of PPARa and target genes involved in fatty acid oxidation in the
fetal hearts. Increased concentrations of triglycerides, cholesterol, and phospholipids were
found in the hearts of fetuses of diabetic rats. Maternal treatments with diets supplemented
with 6% olive oil or 6% safflower oil, enriched in unsaturated fatty acids that can activate PPARs,
led to few changes in lipid concentrations, but up-regulated PPARa expression in fetal hearts.
NO production, which was increased in the hearts of male and female fetuses in the diabetic
group, and lipoperoxidation, which was increased in the hearts of male fetuses in the diabetic
group, was reduced by the maternal treatments supplemented with safflower oil. In conclusion,
impaired PPARa expression, altered lipid metabolism, and increased oxidative and nitridergic
pathways were evidenced in hearts of fetuses of diabetic rats and were regulated in a genderdependent manner by treatments enriched with PPAR ligands.
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Introduction
Maternal diabetes can impair the development of the
fetus and lead to adverse consequences evident in the
offspring both during the perinatal period and in later life
(Michael Weindling 2009, Simeoni & Barker 2009, Ali &
Dornhorst 2011). The fetal heart is a target organ that can
be structurally and functionally affected by maternal
http://jme.endocrinology-journals.org
DOI: 10.1530/JME-14-0063
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diabetes (Molin et al. 2004, Corrigan et al. 2009). In the
fetal period, the heart uses glucose and lactate as main
oxidative substrate sources and then switches to fatty
acids in the neonate, to assure proper energy metabolism
according to dietary and physiological conditions
(Finck 2007).
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Peroxisome proliferator-activated receptor alpha
(PPARa), the first of the three PPAR isotypes identified,
is an important regulator of myocardial lipid metabolism that also contributes to the control of
inflammation and oxidative stress (Wahli & Michalik
2012, Lee et al. 2013, Palomer et al. 2013). PPARa is
expressed in the fetal heart and its expression increases
after birth (Abbott 2009). In mouse models of diabetes, the
fetal heart shows decreased PPARa expression (Lindegaard
& Nielsen 2008). In experimental models, both PPARa
inactivation and overexpression can lead to metabolic
alterations in the heart (Finck 2007, Lindegaard & Nielsen
2008). In adult diabetic patients, chronic inflammation
and alterations in energy and lipid homeostasis are
involved in cardiac dysfunction (Palomer et al. 2013).
In the cardiovascular system, several metabolic and antiinflammatory pathways are regulated by ligands of the
nuclear receptor PPARa both through transactivation and
transrepression mechanisms (Lefebvre et al. 2006, Wahli
& Michalik 2012). Fibrates are pharmacological ligands of
PPARa used to regulate dyslipidemia, which ameiorate
cardiovascular diseases and reduce pro-inflammatory
markers in the heart of diabetic patients (Lefebvre et al.
2006, Lee et al. 2013). The natural ligands of PPARa
include leukotriene (LT) B4, and certain unsaturated
fatty acids such as oleic acid and linoleic acid, which
can be efficiently transferred through the placenta
(Hihi et al. 2002, Herrera et al. 2006, Jawerbaum &
Capobianco 2011).
Diabetes induces a pro-oxidant and pro-inflammatory
state in both the non-pregnant and the pregnant states
(Calkin & Thomas 2008, Lappas et al. 2011). In previous
studies, in a mild diabetic rat model during pregnancy we
have evaluated and found alterations in PPARa expression
and signaling in different fetal organs such as the liver and
the lungs (Jawerbaum & White 2010, Martinez et al.
2011a, Kurtz et al. 2012). In the current study, we used the
same diabetic rat model to address whether the fetal heart
has altered expression of PPARa and lipid-oxidizing
enzymes, lipid content, nitric oxide (NO) production,
and lipid peroxidation. We also carried out fetal treatments with LTB4 and evaluated maternal diets enriched
with 6% olive oil or 6% safflower oil to identify putative
changes in PPARa expression, lipid metabolism, and
oxidative and nitridergic pathways. Considering the
known sexual differences in PPAR signaling and in
metabolic and heart diseases, the hearts from both female
and male fetuses were separately analyzed (Kautzky-Willer
& Handisurya 2009, Yoon 2009, Garcia-Patterson et al.
2011, Mosca et al. 2011).
http://jme.endocrinology-journals.org
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Materials and methods
Animals
Albino Wistar rats bred in our animal facility were fed
ad libitum with commercial rat chow (Asociación Cooperativa Argentina, Buenos Aires, Argentina). To induce
diabetes, at 2 days of age, neonates were injected with
streptozotocin (90 mg/kg, s.c., Sigma–Aldrich) diluted in
citrate buffer (0.05 M, pH 4.5, Sigma–Aldrich), as previously
described (Jawerbaum & White 2010, Martinez et al.
2011a). The control animals were injected with citrate
buffer alone. The diabetic state was confirmed in 2-monthold rats before mating. The rats were considered diabetic
when they presented fasting glycemia values higher than
130 mg/dl. The guidelines for the care and use of animals
approved by the local institution were followed (EXP-UBA
0011821), according to the Principles of Laboratory Animal
Care (NIH publication number 85-23, revised 1985, http://
grants1.nih.gov/grants/olaw/references/phspol.htm).
Control and diabetic female rats were mated with
control males. The first day of pregnancy was confirmed by
the presence of sperm cells in vaginal smears. On this day,
both control and diabetic animals were randomized into
two groups: group 1, animals whose fetuses were injected
with the PPARa ligand LTB4 or vehicle on days 19, 20,
and 21 of pregnancy and group 2, animals fed with diets
supplemented with 6% olive oil or 6% safflower oil, enriched
in natural PPAR ligands, from days 1 to 21 of pregnancy.
In group 1, to inject the fetuses, the animals (nZ9
control and nZ9 diabetic rats) were anesthetized in a CO2
chamber on days 19, 20, and 21 of pregnancy and a slight
anesthesia maintained with ether vapors. An abdominal
incision was performed and the left horn of the uterus was
exposed. The fetuses were numbered from the ovary and
alternatively injected with LTB4 (0.1 nmol/fetus dissolved
in vehicle; Cayman Chemical Co., Ann Arbor, MI, USA) or
vehicle (0.3 ml ethanol/fetus, dissolved in saline solution)
subcutaneously on their backs through the uterine wall, as
described previously (Kurtz et al. 2012). The entire surgery
lasted !10 min and the animals were completely recovered after 15 min. On day 21 of pregnancy and after 3 h
of the last injection, the rats were killed and the hearts
from female and male fetuses were explanted and
preserved as described below.
In group 2, control and diabetic mothers were fed
from days 1 to 21 of pregnancy either with a standard
diet or with diets enriched in unsaturated fatty acids that
activate PPARs: 6% olive oil (354% enriched in oleic acid)
and 6% safflower oil (226% enriched in linoleic acid)
Published by Bioscientifica Ltd.
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(nZ9 in each experimental group), as described previously
(Martinez et al. 2012). The compositions of the diets were
as follows: standard diet (g/100 g): carbohydrates (50);
proteins (25); fat (5), major fatty acids 16:0 (0.58), 18:0
(0.16), 18:1 (1.27), 18:2 (1.99), 18:3 (0.73); olive oilsupplemented diet (g/100 g): carbohydrates (48); proteins
(24); fat (11), major fatty acids 16:0 (1.55), 18:0 (0.26),
18:1 (5.77), 18:2 (2.41), 18:3 (0.57); and safflower oilsupplemented diet (g/100 g): carbohydrates (47); proteins
(23); fat (11), major fatty acids 16:0 (0.97), 18:0 (0.25), 18:1
(1.81), 18:2 (6.49), 18:3 (0.55).
All animals from groups 1 and 2 were killed by
decapitation on day 21 of pregnancy. Maternal and fetal
blood samples were collected in heparinized tubes and
plasma was preserved at K80 8C. Under a stereomicroscope, fetuses were sexed and the fetal hearts explanted.
The hearts from male and female fetuses were randomly
selected and either preserved in RNA stabilization solution
(RNAlater, Invitrogen) for further evaluation of gene
expression of PPARa and lipid-oxidizing enzymes or
preserved at K80 8C for further analysis of lipid content,
NO production, and lipoperoxidation.

Metabolic assays
Glycemia values were measured by the Accu-Chek reagent
strips and a glucometer Accu-Chek (Bayer Diagnostics) in
blood samples obtained from the tail vein of the mothers.
The maternal and fetal glycemia and triglyceridemia
were measured in plasma by an enzymatic colorimetric
commercial kit (Wiener Lab, Rosario, Argentina).

Expression of PPARa and rate-limiting enzymes in lipid
oxidation
The gene expression of PPARa and the rate-limiting
enzymes in lipid oxidation of acyl CoA oxidase (ACO)
and carnitine palmitoyltransferase 1 (CPT1) were evaluated
by RT-PCR, a semi-quantitative method, as described
previously (Kurtz et al. 2012). Briefly, RNA was extracted
from the hearts of one female and one male fetus from each
rat (nZ9 rats in each experimental group) with TRI reagent
(Genbiotech, Buenos Aires, Argentina) in accordance with
the manufacturer’s instructions. cDNA was synthesized by
incubating 1 mg of extracted RNA in a first-strand buffer
containing MMLV enzyme (Promega), random primer
hexamers, and each of all four dNTPs (Invitrogen), in
accordance with the MMLV manufacturer’s instructions.
cDNA (2 ml, selected to work within the linear range)
was amplified by PCR in a buffer containing dNTPs,
http://jme.endocrinology-journals.org
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magnesium chloride solution, Taq polymerase (GoTaq
Polymerase, Promega), and each specific primer in accordance with the Taq polymerase manufacturer’s instructions.
Primers for PPARa were as follows: forward,
0
5 -TCACACAATGCAATCCGTTT-3 0 and reverse: 5 0 -GGCCTTGACCTTGTTCATGT-3 0 , whose amplification product
is a 177-bp fragment (Kurtz et al. 2012). The primers for
Aco were as follows: forward: 5 0 -CCAATCACGCAATAGTTCTGG-3 0 and reverse, 5 0 -CGCTGTATCGTATGGCGAT-3 0 , whose amplification product is a 363-bp
fragment (Lillycrop et al. 2005). The primers for Cpt1
were as follows: forward, 5 0 -TATCGTCGCACATTAGACCGT-3 0 and reverse, 5 0 -CATCTATGACCTCCTGGCACT-3 0 , whose amplification product is a 715-bp
fragment (Cheng et al. 2004). The primers for the
ribosomal protein L30, used as an internal control, were
as follows: forward, 5 0 -CCATCTTGGCGTCTGATCTT-3 0
and reverse, 5 0 -GGCGAGGATAACCAATTTC-3 0 , whose
amplification product is a 201-bp fragment (Primer
3 Software, Cambridge, MA, USA). The initial step in the
reaction was 95 8C for 5 min, followed by 33 cycles for
PPARa, 33 cycles for ACO, 34 cycles for CPT1, and 26
cycles for L30, as selected to work within the linear range.
Each cycle consisted of denaturation at 95 8C for 15 s,
primer annealing at 58 8C for 30 s, and extension at 72 8C
for 15 s. The resulting products were separated on a 2%
agarose gel and stained with SYBR safe (Invitrogen). The
images were taken with an ImageQuant spectrophotometer (GE Healthcare, Buckinghamshire, UK) and
the density of the bands was quantified with the Image J
Software (NIH, Bethesda, MD, USA) and normalized to L30.

Analysis of lipid content
Lipid content was determined by thin layer chromatography, as described previously (Martinez et al. 2011a).
Briefly, hearts from three female or three male fetuses
from each rat were pooled and homogenized (nZ9 rats
in each experimental group) in 500 ml PBS and protein
content in the homogenates was measured by the
Bradford assay. The tissue lipids were extracted from
470 ml of each homogenate by three rounds of organic
extraction in methanol:chloroform (2:1). The lipids
were developed by thin layer chromatography in 0.2 mm
silica gel plates (Merck), using hexane:ether:acetic acid
(80:20:2, v:v:v) as the developing solvent mixture. The
lipid species were stained with iodine vapors, identified,
and quantified by comparison with known the amounts
of standards on the same plate, and densitometric analysis was performed using the Image J Software.
Published by Bioscientifica Ltd.
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Evaluation of NO production
NO production was evaluated by measuring the concentration of its stable metabolite nitrates/nitrites, as
previously determined (Kurtz et al. 2012), by using a
commercial assay kit (Cayman Chemical Co.). For this,
hearts of two female or two male fetuses from each rat
were pooled and homogenized (nZ9 rats in each
experimental group) in 1 ml Tris–HCl buffer of pH 7.6,
and an aliquot was separated for protein analysis.
The nitrates in the supernatant were reduced to nitrites
by nitrate reductase, and the total nitrites were measured
by the Griess method (Green et al. 1982). The optical
densities were measured at 540 nm in a microtiter plate
using nitrates as standard.

Journal of Molecular Endocrinology

Analysis of lipoperoxidation
Lipoperoxidation was assessed as described previously
(Martinez et al. 2011a), by measuring the concentrations
of thiobarbituric acid reactive substances (TBARS), a
method widely used to assess peroxidation of fatty acids
(Ohkawa et al. 1979). Briefly, hearts from two female or
two male fetuses from each rat were pooled and
homogenized (nZ9 rats in each experimental group) in
100 mM Tris–HCl buffer (0.1 mM, pH 7.4). The homogenate was added with 40% trichloroacetic acid (Merck). After
centrifugation, the supernatant was added with an equal
volume of thiobarbituric acid (46 mM; Sigma–Aldrich),
the solution was heated at 95 8C and, after cooling,
quantified spectrophotometrically at 540 nm. Different
concentrations of malondialdehyde (Sigma–Aldrich)
subjected to the same conditions as the tissue homogenates were used as standards.
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triglyceridemia were increased in both mothers and
fetuses from diabetic rats compared with controls on
day 21 of pregnancy (P!0.01), with no gender differences
and no effects of injecting with the PPARa activator LTB4
on fetus in the groups evaluated (Table 1).
When we evaluated the expression of PPARa, a
regulator of lipid metabolism and anti-inflammatory
processes in the heart of adults and in different fetal
tissues (Martinez et al. 2011a, Kurtz et al. 2012, Lee et al.
2013), we found a decrease in PPARa expression in the
hearts of male but not of female fetuses in the diabetic
group compared with controls (P!0.01, Fig. 1A). We also
evidenced the ability of the PPARa ligand LTB4 (0.1 nmol,
injected into the fetuses through the uterine wall on days
19, 20, and 21 of pregnancy) to upregulate PPARa
expression in the hearts of female and male fetuses in
the diabetic group and of male fetuses in the control group
(P!0.01, Fig. 1A). We next evaluated the expression of Aco
and Cpt1, relevant PPARa-target genes that code for ratelimiting enzymes in lipid oxidation. We found a decrease
in Aco expression in the hearts of male fetuses but not
of female fetuses in the diabetic group compared with
controls (P!0.05, Fig. 1B), and a decrease in Cpt1
expression in the hearts of male and female fetuses in
the diabetic group compared with controls (P!0.01,
Fig. 1C). The fetal injections with the PPARa ligand LTB4
(0.1 nmol) led to an increase in Aco expression in the
hearts of female and male fetuses in the diabetic group as
well as in the hearts of female fetuses in the control group

Table 1

Maternal and fetal metabolic parameters in control

and diabetic rats from experimental group 1 whose fetuses
were injected with LTB4 or vehicle on days 19, 20, and 21 of
pregnancy. Values represent meanGS.E.M., obtained from

Statistical analysis

mothers and female or male fetuses from nZ9 rats in

Data are presented as meansG S. E. M. Groups were
compared by two-way ANOVA in conjunction with
Bonferroni’s test. A P value !0.05 was considered
statistically significant.

experimental group 1. Two-way ANOVA in conjunction with
Bonferroni’s test was performed
Glycemia (mg/dl)

Triglyceridemia (g/l)

Decreased expression of PPARa and enzymes involved in
lipid oxidation in the hearts of fetuses from diabetic rats:
effects of fetal treatments with a PPARa activator

Maternal data
Control
Diabetic
Fetal data (combined
males/females)
Control vehicle
Control LTB4
Diabetic vehicle
Diabetic LTB4

We first analyzed the metabolic parameters of
experimental group 1 and found that glycemia and

a
P!0.001 diabetic vs control; bP!0.01, cP!0.001 diabetic with vehicle vs
control with vehicle.

Results
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92G8
214G24a

1.9G0.3
4.0G0.3a

47G5
49G10
146G11b
135G9

0.54G0.06
0.60G0.05
0.89G0.07c
0.88G0.04
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Figure 1
(A) PPARa expression, (B) Aco expression, and (C) Cpt1 expression in the
hearts of fetuses from control and diabetic rats injected with the PPARa
agonist LTB4 or with vehicle on days 19, 20, and 21 of pregnancy. Values
represent meanGS.E.M., obtained from female or male fetuses from nZ9
rats in each experimental group. Two-way ANOVA in conjunction with
Bonferroni’s test was performed. *P!0.05, **P!0.01 diabetic with vehicle
vs control with vehicle; ##P!0.01 control with LTB4 vs control with vehicle;
and †P!0.05, ††P!0.01 diabetic with LTB4 vs diabetic with vehicle.

(P!0.05, Fig. 1B). The fetal treatments with LTB4 only led
to an increase in Cpt1 expression in the hearts of male
fetuses in the diabetic group (P!0.01, Fig. 1C).

Effect of maternal diets enriched with olive oil or
safflower oil on lipid concentrations
Considering the sex-dependent changes observed in the
expression of PPARa and its target genes involved in lipid
oxidation in the fetal hearts of diabetic rats, we evaluated
lipid concentrations in the hearts of female and
male fetuses from control and diabetic rats. We found
http://jme.endocrinology-journals.org
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increased concentrations of triglycerides (P!0.001),
cholesterol (P!0.05), and phospholipids (P!0.05) and
no changes in cholesteryl esters in the heart of female and
male fetuses in the diabetic group compared with
controls (Fig. 2). As we have previously shown that
dietary supplementation with 6% olive oil and 6%
safflower oil can regulate lipid content in different fetal
tissues and through developmental stages (Capobianco
et al. 2008a,b, Kurtz et al. 2014), in this study we analyzed
the effect of these dietary supplementations, administered from days 1 to 21 of pregnancy. The metabolic
parameters evaluated in these animals (experimental
group 2) are shown in Table 2. On day 21 of pregnancy,
increased glycemia and triglyceridemia were observed in
both diabetic mother and fetus rats fed the standard diet
compared with controls fed the standard diet (P!0.001),
with no gender differences, and no effects of the diets
supplemented with 6% olive oil or 6% safflower oil in the
groups evaluated (Table 2).
When we analyzed the effect of the maternal diets
supplemented with 6% olive and 6% safflower oils on
lipid content in the fetal heart, we observed only a few
changes, all of them evidenced in the hearts of female
fetuses: an increase in triglycerides in the diabetic group
fed the olive oil-supplemented diet, a decrease in
cholesterol in the control group fed the olive oilsupplemented diet, and an increase in cholesteryl esters
in the control group fed the safflower oil-supplemented
diet (P!0.05, Fig. 2).
The absence of marked effects on lipid content was
evidenced even when the olive oil- and the safflower oilsupplemented diets induced relevant changes in PPARa
expression in the hearts of both female and male fetuses
(Fig. 3A). Indeed, PPARa expression was negatively
regulated by the olive oil-supplemented diet in the hearts
of female fetuses in the diabetic group and positively
regulated by both the olive oil- and the safflower oilsupplemented diets in the hearts of male fetuses in control
and diabetic groups (P!0.05, Fig. 3A). No effects were
observed when expression of Aco and Cpt1 was evaluated
in the control and the diabetic groups fed olive oil- and
safflower oil-supplemented diets compared with the
respective groups fed the standard diet (Fig. 3B and C).

Effect of maternal diets enriched with olive oil or
safflower oil on NO production
Our previous studies suggest that PPARa is a relevant
regulator of NO production in different fetal organs
(Martinez et al. 2011b, Kurtz et al. 2012). Excessive
Published by Bioscientifica Ltd.
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Figure 2
Lipid concentrations in the hearts of fetuses from control and diabetic rats fed with a standard, a 6% olive oil-supplemented or a 6% safflower
oil-supplemented diet from days 1 to 21 of pregnancy. Values represent meanGS.E.M., obtained from female or male fetuses from nZ9 rats in each
experimental group. Two-way ANOVA in conjunction with Bonferroni’s test was performed. *P!0.05, ***P!0.001 diabetic with standard diet vs control
with standard diet; #P!0.05 control with oil-supplemented diets vs control with standard diet; and †P!0.05 diabetic with oil-supplemented diets vs diabetic
with standard diet.

production of NO can affect embryo and fetal development and is a marker of a pro-inflammatory state
(Lappas et al. 2011). In this work, we found increased
nitrates/nitrites concentrations, an index of NO production, in the hearts of female and male fetuses of
diabetic rats when compared with controls (P!0.01,
Fig. 4). We also evidenced the ability of the maternal

Table 2

diets supplemented with olive oil to decrease nitrates/
nitrites (stable NO metabolites) in the hearts of male
fetuses in the diabetic group (P!0.01, Fig. 4), and the
ability of the maternal diets supplemented with 6%
safflower oil to decrease nitrates/nitrites in the hearts of
both female and male fetuses in the diabetic group
(P!0.01, Fig. 4).

Maternal and fetal metabolic parameters in control and diabetic rats from experimental group 2 fed with standard diet

supplemented with or without 6% olive oil or 6% safflower oil from days 1 to 21 of pregnancy. Values represent meanGS.E.M.,
obtained from mothers and female or male fetuses from nZ9 rats in experimental group 2. Two-way ANOVA in conjunction with
Bonferroni’s test was performed
Control

a

Standard
diet

Standard diet
supplemented with
6% safflower oil

98G12
2.01G0.15

230G15a
4.15G0.20a

225G15
3.87G0.22

230G14
3.92G0.16

44G6
0.48G0.05

146G11a
0.98G0.07a

129G15
1.05G0.10

120G23
0.90G0.08

Standard diet
supplemented with
6% safflower oil

93G7
2.1G0.15

105G9
2.03G0.25

46G7
0.52G0.05

45G9
0.59G0.06

Standard
diet

Maternal data
Glycemia (mg/dl)
Triglyceridemia (g/l)
Fetal data (combined
males/females)
Glycemia (mg/dl)
Triglyceridemia (g/l)

Diabetic
Standard diet
supplemented with
6% olive oil

Standard diet
supplemented with
6% olive oil

P!0.01 diabetic with standard diet vs control with standard diet.
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6% safflower oil from days 1 to 21 of pregnancy.
Lipoperoxidation was observed to be increased in the
hearts of male fetuses (P!0.01), although not in the hearts
of female fetuses from diabetic rats when compared with
controls (Fig. 5). We also evidenced the ability of the
maternal diets supplemented with 6% safflower oil,
although not of those supplemented with 6% olive oil, to
decrease lipoperoxidation in the hearts of male fetuses in
the diabetic group (P!0.01, Fig. 5).
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Figure 3
(A) PPARa expression, (B) Aco expression, and (C) Cpt1 expression in hearts
of fetuses from control and diabetic rats fed with a standard, a 6% olive
oil-supplemented or a 6% safflower oil-supplemented diet from days 1 to
21 of pregnancy. Values represent meanGS.E.M., obtained from female or
male fetuses from nZ9 rats in each experimental group. Two-way ANOVA
in conjunction with Bonferroni’s test was performed. *P!0.05, **P!0.01
diabetic with standard diet vs control with standard diet; ##P!0.01,
###
P!0.001 control with oil-supplemented diets vs control with standard
diet; and †P!0.05, ††P!0.01 diabetic with oil-supplemented diets vs
diabetic with standard diet.

In this study, we found sex-dependent increases in lipid
content, NO production, and lipoperoxidation, together
with decreased expression of PPARa and rate-limiting
enzymes involved in lipid oxidation in the hearts of term
fetuses of diabetic rats. Fetal or maternal treatments with
PPAR activators regulated most of the parameters evaluated in a sex-dependent way. PPARa expression was
upregulated both by fetal treatments with PPARa ligands
and by maternal treatments with diets enriched with PPAR
ligands during gestation, thus indicating the ability of
these treatments to amplify PPARa signaling pathways in
the fetal heart.
PPARa is a master regulator of lipid oxidation in
metabolic tissues such as liver, kidney, and heart (Lefebvre
et al. 2006). In this study, we observed a decrease in PPARa
and its target genes Aco and Cpt1 in the hearts of male
fetuses from diabetic rats, although only a decrease in Cpt1
in the hearts of female fetuses in the diabetic group when
compared with controls. These decreases, together with
Female fetuses
8

††
6

4

2

0

Effect of maternal diets enriched with olive oil or
safflower oil on lipoperoxidation
As PPARa activation can regulate anti-oxidant pathways
in different tissues during development (Martinez et al.
2011a,b) and lipoperoxidation is a marker of oxidative
stress previously found to be increased in the fetuses
and placentas of diabetic rats ( Jawerbaum & White 2010),
we next evaluated lipoperoxidation in the heart of
fetuses from control and diabetic rats that were treated
with or without diets supplemented with 6% olive oil or
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Figure 4
Nitric oxide (NO) production, evaluated through the concentration of NO
stable metabolites nitrates/nitrites, in the hearts of fetuses from control
and diabetic rats fed with a standard, a 6% olive oil-supplemented, or a 6%
safflower oil-supplemented diet from days 1 to 21 of pregnancy. Values
represent meanGS.E.M., obtained from female or male fetuses from nZ9
rats in each experimental group. Two-way ANOVA in conjunction with
Bonferroni’s test was performed. **P!0.01, ***P!0.01 diabetic with
standard diet vs control with standard diet and ††P!0.01 diabetic with
oil-supplemented diets vs diabetic with standard diet.
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Figure 5
Lipoperoxidation, examined through the concentrations of TBARS, in the
hearts of fetuses from control and diabetic rats fed with a standard, a 6%
olive oil-supplemented or a 6% safflower oil-supplemented diet from days
1 to 21 of pregnancy. Values represent meanGS.E.M., obtained from female
or male fetuses from nZ9 rats in each experimental group. Two-way
ANOVA in conjunction with Bonferroni’s test was performed. **P!0.01
diabetic with standard diet vs control with standard diet and ††P!0.01
diabetic with oil-supplemented diets vs diabetic with standard diet.

the increased maternal and fetal triglyceridemia, may be
involved in the overaccumulation of lipids in the hearts of
fetuses in the diabetes experimental model evaluated.
Previous studies performed in Akita mice, a more severe
genetic model of diabetes, showed no changes in
triglyceride content but a decrease in lipid transporters
and in the expression of PPARa in the fetal hearts
(Lindegaard & Nielsen 2008). It is known that PPARa
regulates lipid oxidation in the hearts of neonates and
adults (Finck 2007), but its function as a lipid metabolic
sensor is not yet clear in the fetuses. In this work, we found
that the PPARa ligand LTB4 is able to increase the
expression of the lipid-oxidizing enzymes ACO and
CPT1 in the fetal heart. Nevertheless, maternal diets
enriched with PPAR ligands did not increase the
expression of ACO and CPT1, and did not lead to a
decreased content of lipid species in the fetal heart. It is
known that PPAR ligands decrease lipid content in the
fetal liver (Martinez et al. 2011a) and that the liver is the
main target in treatment with PPARa ligands in adult
animals (Finck 2007). However, in this study, we found
that both the maternal diets enriched with PPAR ligands
and the fetal treatments with the PPARa agonist LTB4 led
to an increased expression of PPARa in the fetal heart,
indicating that PPARa signaling is stimulated in this fetal
organ by the given treatments. Several studies have shown
that different PPAR ligands can induce different conformational changes in PPARs, as well as different biological
responses (Hostetler et al. 2005, Gregoire et al. 2009).
Indeed, ligand activation stabilizes the interaction
between PPAR and RXR, enhances the formation of
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DOI: 10.1530/JME-14-0063

Ñ 2014 Society for Endocrinology
Printed in Great Britain

53:2

244

functional PPAR–RXR heterodimers, and can also regulate
the heterodimerization with different partners (Harmon
et al. 2011, Balanarasimha et al. 2014). The resulting
interaction plays a key role leading to the formation of
complexes, which result in gene activation or repression
(Harmon et al. 2011). Thus, it is possible that transactivation pathways are those mainly activated by LTB4 in the
fetal heart, leading to the expression of regulation of lipid
oxidizing enzymes, whereas transrepression pathways are
those mainly activated by the maternal dietary treatments
with unsaturated fatty acids. However, further studies are
needed to address this point, as this work was limited
due to the evaluation of PPAR ligands in different in vivo
approaches. The formation of PPAR complexes and the
resulting activity are tissue-dependent, and PPARs’
capacity to activate or repress metabolic and proinflammatory pathways was similarly evidenced using
different in vivo and in vitro approaches in the fetal liver
and lung (Harmon et al. 2011, Martinez et al. 2011a, Kurtz
et al. 2012).
In the heart, relevant extra-metabolic functions
related with the control of the pro-inflammatory and
pro-oxidant environment can be exerted by PPARa
activation (Palomer et al. 2013). We found that NO
production, which is increased in pro-inflammatory states
(Lappas et al. 2011), was increased in the hearts of male
and female fetuses from diabetic rats. Previous research
has demonstrated that diabetic embryopathy is related
with NO overproduction, and that different fetal organs
such as liver, lung, and placenta have increased NO
production when being developed in a diabetic mother
(Martinez et al. 2011a,b, Kurtz et al. 2012). Moreover, in
the presence of oxidative stress, NO overproduction leads
to the formation of peroxynitrites, which induce severe
damage to different organs, including the heart (Mungrue
et al. 2002, Lappas et al. 2011). Thus, it was interesting
to find that maternal diets enriched with 6% olive oil
(only in male fetuses) and 6% safflower oil (in both male
and female fetuses) prevented the overproduction of NO
in the hearts of fetuses from diabetic rats. Future research
is needed to identify whether putative epigenetic changes
are involved in the fetal changes observed, and to analyze
the effects of these treatments in the heart of neonates.
It is known that cardiac dysfunction is sex-dependent,
possibly in part due to the differential ability of estrogens to regulate lipid metabolism (Kautzky-Willer &
Handisurya 2009, Oosthuyse & Bosch 2012). PPARa
signaling is also sex-dependent due to the effects of
estrogens and androgens on PPARa expression and due
to the use of common coactivators by different nuclear
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receptors (Collett et al. 2000, Yoon 2009, Benz et al. 2012).
Indeed, we have previously found sex-dependent effects of
PPARa agonists in different tissues even at fetal stage
(Kurtz et al. 2014). Interestingly, in this study, we found
that only the heart of male fetuses showed increased
lipoperoxidation in the diabetic group. Increased oxidative stress, related with impairments in energy metabolism, stress in endoplasmic reticulum, and apoptosis, has
been described in the heart of adult diabetic animals
(Li et al. 2007, Palomer et al. 2013).
Previous research has identified the ability of maternal
diets enriched with PPAR ligands to reduce oxidative
stress during embryo development and to reduce proinflammatory markers in the placenta and fetal lungs
(Higa et al. 2012, Kurtz et al. 2012, Martinez et al. 2012).
A limitation of this study was that, due to the lack of
sufficient biological material, we were unable to measure
NO production and lipid peroxidation in the LTB4-treated
group. Although the 6% olive oil-supplemented diet is
enriched with both oleic acid and polyphenols that can
exert antioxidant properties (Martin-Pelaez et al. 2013),
only the maternal treatments supplemented with 6%
safflower oil were able to decrease lipoperoxidation in the
hearts of male fetuses from diabetic rats. This may be due
to the increased ability of the safflower oil-supplemented
diet to amplify PPARa signaling pathways. Indeed, we
showed that this diet leads to a greater increase in PPARa
expression in the hearts of fetuses from diabetic rats.
In addition, safflower oil is enriched with linoleic acid,
which can activate PPARs by itself and by the production
of eicosanoids that can further activate PPARs ( Jawerbaum
& Capobianco 2011).
In conclusion, the fetal hearts evaluated in the mild
diabetic rat model were profoundly affected, as evidenced
by overaccumulation of lipid, increased NO, and lipoperoxidation, which may lead to heart dysfunction later in life.
These alterations were more marked in the hearts of male
fetuses, which showed reduced expression of PPARa and
target genes involved in fatty acid oxidation. Moreover,
PPARa signaling in the fetal heart was mainly activated
by the maternal dietary treatment enriched with 6%
safflower oil, leading to the regulation of lipoperoxidation
and NO production, by ameliorating the pro-oxidant
and pro-inflammatory environment and thus may prevent
the future development of cardiac dysfunction.
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